We are developing therapeutic cells via bioengineering approaches to serve as a living drug factory for producing macromolecular therapeutics directly at diseased sites.

We engineer advanced therapeutic delivery systems by synthesizing and formulating novel therapeutic molecules to overcome biological barriers and minimize off-target side effects.